Denise Goode
Direktor/Vorstandsmitglied bei ABLIVA AB
Profil
Denise Goode is currently the Chief Executive Officer & Director at Qed Life Sciences Ltd., the Independent Director at Abliva AB, the Independent Director at Alligator Bioscience AB, and the Vice President-Business Development at AnaMar AB.
Previously, Ms. Goode served as the Non-Executive Director at Dechra Pharmaceuticals Plc and as a Director at OBN (UK) Ltd.
Ms. Goode completed her undergraduate degree at The University of Manchester.
Aktive Positionen von Denise Goode
| Unternehmen | Position | Beginn |
|---|---|---|
| ABLIVA AB | Direktor/Vorstandsmitglied | 27.04.2018 |
| ALLIGATOR BIOSCIENCE AB | Direktor/Vorstandsmitglied | 09.05.2022 |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | - |
| Qed Life Sciences Ltd. | Vorstandsvorsitzender | 01.11.2014 |
Ehemalige bekannte Positionen von Denise Goode
| Unternehmen | Position | Ende |
|---|---|---|
| DECHRA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 30.11.2021 |
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Denise Goode
| The University of Manchester | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABLIVA AB | Health Technology |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Dechra Pharmaceuticals Plc
 Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
AnaMar AB
AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Health Technology |
OBN (UK) Ltd.
OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Commercial Services |
| Qed Life Sciences Ltd. |
